Anna Sureda, MD
Expert in CAR-T therapy and immunotherapeutic approaches in lymphoma treatment
Best podcasts with Anna Sureda, MD
Ranked by the Snipd community
May 16, 2024 • 13min
The future of CAR-T therapy in lymphoma, addressing the risk of secondary malignancy & the optimal sequencing of these agents with bispecific antibodies
Dr. Anna Sureda, an expert in CAR-T therapy, discusses the future of CAR-T therapy in lymphoma and the risk of secondary malignancies. Dr. Manali Kamdar provides an overview of CAR-T products and bispecific antibodies in large B-cell lymphoma, focusing on optimal sequencing for these agents to enhance efficacy.
